IL17A and colitis: In previous work, we identified liposomes containing the synthetic TLR ligands GLA and 3M-052 as a promising adjuvant formulation to promote antigen-specific IFNγ/IL-17A-associated immunogenicity and protective efficacy in the amebic colitis mouse model (8, 9).